John Ragard - 31 Dec 2024 Form 4 Insider Report for Aspira Women's Health Inc. (AWH)

Role
Director
Signature
/s/ John Ragard
Issuer symbol
AWH
Transactions as of
31 Dec 2024
Net transactions value
$0
Form type
4
Filing time
08 Jan 2025, 18:47:35 UTC
Previous filing
22 Nov 2024
Next filing
01 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AWH Common Stock Options Exercise $0 +4,844 +4% $0.000000 125,047 31 Dec 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AWH Restricted Stock Units Options Exercise $0 -4,844 -33% $0.000000 9,687 31 Dec 2024 Common Stock 4,844 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.
F2 Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.
F3 On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4.